Australian regulator Therapeutic Goods Administration ends ban on off-label use of ivermectin

05/10/2023 / By Olivia Cook

Australia’s Department of Health and Aged Care has announced that prescribing ivermectin for off-label uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious disease specialists starting June 1.

The restriction was introduced in September 2021 because of government concerns about the use of ivermectin to treat the Wuhan coronavirus (COVID-19) instead of vaccines and other treatments peddled by Big Pharma and approved by health agencies.

In Australia, ivermectin is only approved by the Therapeutic Goods Administration (TGA) for the treatment of river blindness, threadworms of the intestines and scabies.

In its final decision published on May 3, the TGA removed the restriction through its scheduling in the Poisons Standard because there is sufficient evidence that the safety risks to individuals and public health are low when prescribed by a general practitioner in the current health climate.

This considers the evidence and awareness of medical practitioners about the risks and benefits of ivermectin and the low potential for any shortages of ivermectin for its approved uses.

The final decision has been made according to the process required under the Therapeutic Goods Act 1989. It takes into account advice from the independent Advisory Committee on Medicines Scheduling (ACMS) and two rounds of public consultation.

However, the TGA still does not endorse off-label prescription of ivermectin for the treatment or prevention of COVID-19 despite evidence of its efficacy.

Physician: Ivermectin is as effective as monoclonal antibodies in treating COVID-19 infection

During the April 24 episode of Brighteon.TV program “America Can We Talk?” with Debbie Georgatos, board-certified ear, nose and throat physician Dr. Mary Talley Bowden said ivermectin is just as effective as monoclonal antibodies in treating COVID-19 infection.

Bowden said she started offering monoclonal antibodies to patients when they first came out and attested to the efficacy of this treatment as her patients managed to recover within 24 hours. She turned to ivermectin when procuring monoclonal antibodies became much more difficult as the government took over distribution.

“Ivermectin might have taken a little bit longer, but that – in combination with other medications – worked very well. I haven’t counted in a while, but last time I counted I had 5,500 patients alive and well because of early treatment,” Bowden said.

Sadly, the physician found herself shut down and kicked out of a doctors’ Facebook group after putting all the results on her website and posting them on social media. She was accused of underestimating the disease, reported NBC News. (Related: Houston Methodist Hospital suspends doctor who advocated use of ivermectin to treat COVID patients.)

In August last year, WND reported that a large study conducted in Brazil found that ivermectin is 92 percent effective at stopping mortality caused by COVID-19.

Endocrinologist Dr. Flavio A. Cadegiani tweeted that ivermectin has a “dose-response effect” when used as a prophylactic. Meaning, “the more you used, the more protection you had.”

Nearly all patients who took ivermectin regularly every 15 days for at least six to eight weeks survived COVID, while those who did not were much more likely to die after the disease ran its course.

Ivermectin is best known for its anti-parasitic properties, but it has also been found to have antiviral properties that can help prevent COVID-19. Studies have shown that ivermectin helps to lower the viral load by inhibiting replication.

According to a study published in the Antiviral Research Journal, a single dose of ivermectin can kill 99.8 percent of the virus within 48 hours. A meta-analysis in the American Journal of Therapeutics showed the drug reduced infection by an average of 86 percent when used preventively.

Liberty Counsel Founder and Chairman Mat Staver said cheap and effective drugs like ivermectin are being denied to the public while pharmaceutical companies make money from COVID-19 shots that are neither safe nor effective.

Studies and personal testimonies have repeatedly shown the effectiveness of ivermectin. The focus should always be on helping save lives rather than putting more money in the pockets of Big Pharma.

Visit IvermectinScience.com to know more about ivermectin.

Watch this video to learn the truth about ivermectin.

This video is from the Health Secret channel on Brighteon.com.

Australian regulator Therapeutic Goods Administration ends ban on off-label use of ivermectin

Physician: Ivermectin is as effective as monoclonal antibodies in treating COVID-19 infection

More related stories:

RECENT NEWS & ARTICLES